Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Synthesis of Novel 2-Aryl-3-(2-morpholinoethyl)-1,3-thiazinan-4-ones Via Ultrasound Irradiation

Full text
Author(s):
Daniela P. Gouvêa [1] ; Gabriele A. Berwaldt [2] ; Patrícia D. Neuenfeldt [3] ; Ricardo J. Nunes [4] ; Wanda P. Almeida [5] ; Wilson Cunico [6]
Total Authors: 6
Affiliation:
[1] Universidade Federal de Pelotas. Laboratório de Química Aplicada a Bioativos - Brasil
[2] Universidade Federal de Pelotas. Laboratório de Química Aplicada a Bioativos - Brasil
[3] Universidade Federal de Santa Catarina. Laboratório Estrutura e Atividade - Brasil
[4] Universidade Federal de Santa Catarina. Laboratório Estrutura e Atividade - Brasil
[5] Universidade Estadual de Campinas. Laboratório de Desenvolvimento de Fármacos e Medicamentos - Brasil
[6] Universidade Federal de Pelotas. Laboratório de Química Aplicada a Bioativos - Brasil
Total Affiliations: 6
Document type: Journal article
Source: Journal of the Brazilian Chemical Society; v. 27, n. 6, p. 1109-1115, 2016-06-00.
Abstract

This study describes the synthesis of fourteen thiazinanones from a multicomponent reaction of 2-morpholinoehtylamine (as primary amine), arenealdehydes (as carbonyl compound) and the mercaptopropionic acid using both conventional (thermal heating) and ultrasound methodologies. Through thermal heating methodology, the thiazinanones were obtained in 49 to 97% yields for 16 hours and through sonochemistry methodology, the reaction time was reduced for 25 minutes with yields 41 to 88%. The full identification and characterization of unpublished heterocycles were achieved by proton (1H) and carbon 13 (13C) nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry and infrared. Some of them were also characterized by elemental analysis. (AU)

FAPESP's process: 13/18203-5 - Synthesis of molecular hybrids derived from 4-quinolones as potential drug candidates to treat Alzheimer's Disease
Grantee:Wanda Pereira Almeida
Support Opportunities: Regular Research Grants